MedaSync Gains Strategic Investment from Omega Healthcare

Aug 28, 2025
MedaSync has secured a strategic investment from Omega Healthcare Investors, Inc., to accelerate the growth of its AI-powered reimbursement software for skilled nursing facilities.

MedaSync has secured a strategic investment from Omega Healthcare Investors, Inc., a leading real estate investment trust focused on skilled nursing and assisted living facilities. This investment, announced in a press release, aims to accelerate the adoption of MedaSync's AI-powered reimbursement optimization software, which is designed to reduce administrative burdens in the skilled nursing sector.

MedaSync's platform uses AI to analyze clinical documentation, surfacing reimbursement misalignments and identifying patient needs to ensure high-quality care. The company has seen significant growth, with customer acquisition increasing over 100% year-over-year. As part of the investment, Megan Krull, Senior Vice President of Operations at Omega Healthcare, will join MedaSync's Board of Directors.

The funding will support MedaSync in scaling its innovative SaaS products and expanding its market presence, providing skilled nursing organizations with tools to navigate the complex reimbursement landscape effectively.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.